A
Anne-Michelle Noone
Researcher at Georgetown University
Publications - 40
Citations - 9946
Anne-Michelle Noone is an academic researcher from Georgetown University. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 25, co-authored 39 publications receiving 8665 citations. Previous affiliations of Anne-Michelle Noone include Georgetown University Medical Center & University of North Carolina at Chapel Hill.
Papers
More filters
Journal ArticleDOI
Cancer Incidence Trends Among Asian American Populations in the United States, 1990–2008
Scarlett Lin Gomez,Anne-Michelle Noone,Daphne Y. Lichtensztajn,Steve Scoppa,James T. Gibson,Lihua Liu,Cyllene R. Morris,Sandy Kwong,Kari Fish,Lynne R. Wilkens,Marc T. Goodman,Dennis Deapen,Barry A. Miller +12 more
TL;DR: These data fill a critical knowledge gap concerning the cancer experience of Asian American groups and highlight where increased preventive, screening, and surveillance efforts are needed-in particular, lung cancer among Filipina and Korean women and Asian Indian/Pakistani men, breast cancer among all women, and liver cancer among Vietnamese, Laotian, and Kampuchean women and Filipino, Kampukhean, and Vietnamese men.
Journal ArticleDOI
Cancer survival: an overview of measures, uses, and interpretation.
Angela B. Mariotto,Anne-Michelle Noone,Nadia Howlader,Hyunsoon Cho,Gretchen E Keel,Jessica Garshell,Steven Woloshin,Lisa M. Schwartz +7 more
TL;DR: In this article, the authors describe and disseminate different survival measures and their interpretation in less technical language, and introduce templates to summarize cancer survival statistic organized by their specific purpose: research and policy versus prognosis and clinical decision making.
Journal ArticleDOI
Fractionated stereotactic radiosurgery for reirradiation of head-and-neck cancer.
Keith Unger,Christopher E. Lominska,John F. Deeken,Bruce J. Davidson,Kenneth Newkirk,Gregory J. Gagnon,Jimmy J. Hwang,Rebecca Slack,Anne-Michelle Noone,K. William Harter +9 more
TL;DR: SRS reirradiation for head-and-neck cancer is feasible and encouraging response rates with acceptable toxicity are demonstrated, as well as being associated with improved OS and concurrent chemotherapy in select patients.
Journal ArticleDOI
Trends in endometrial cancer incidence by race and histology with a correction for the prevalence of hysterectomy, SEER 1992 to 2008.
TL;DR: Correcting the incidence rate for hysterectomy prevalence provides more accurate estimates of endometrial cancer risk over time, resulting in higher rates among black women toward the end of the study period.
Journal ArticleDOI
Breast Cancer Adjuvant Chemotherapy Decisions in Older Women: The Role of Patient Preference and Interactions With Physicians
Jeanne S. Mandelblatt,Vanessa B. Sheppard,Arti Hurria,Gretchen Kimmick,Claudine Isaacs,Kathryn L. Taylor,Alice B. Kornblith,Anne-Michelle Noone,Gheorghe Luta,Michelle Tallarico,William T. Barry,Lisa Hunegs,Robin Zon,Michael Naughton,Eric P. Winer,Clifford A. Hudis,Stephen B. Edge,Harvey J. Cohen,Hyman B. Muss +18 more
TL;DR: Older women's preferences and communication with providers are important correlates of chemotherapy use, especially when benefits are more equivocal.